Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (1-10 of 331) with videos related to

Pageof 34
Sort By:
La Revue De Medecine Interne|December 4, 2014
[Confronted to medical error, emphasize its positive aspects]L Degos
La Revue De Medecine Interne|May 1, 1987
[The HLA system: theoretical and epidemiological data. A critical study of its application in pathology]L Degos
Leukemia|November 1, 1992
Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemiaL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
John Hughes Bennett, Rudolph Virchow... and Alfred Donné: the first description of leukemiaL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
One moral, many ethicsL Degos
Presse Medicale (Paris, France : 1983)|October 1, 1983
[Is the origin of cancer known?]L Degos
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Differentiation of human malignant myeloid and lymphoid cells]L Degos
Tissue Antigens|March 1, 1989
Nomenclature for factors of the HLA system. Comments to the nomenclature committeeL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Do we treat a disease or a patient? A subtle difference with dramatic consequencesL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guidelineL Degos
Pageof 34

Showing results (1-10 of 331) with videos related to

Sort By:
Pageof 34
La Revue De Medecine Interne|December 4, 2014
[Confronted to medical error, emphasize its positive aspects]L Degos
La Revue De Medecine Interne|May 1, 1987
[The HLA system: theoretical and epidemiological data. A critical study of its application in pathology]L Degos
Leukemia|November 1, 1992
Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemiaL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
John Hughes Bennett, Rudolph Virchow... and Alfred Donné: the first description of leukemiaL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
One moral, many ethicsL Degos
Presse Medicale (Paris, France : 1983)|October 1, 1983
[Is the origin of cancer known?]L Degos
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Differentiation of human malignant myeloid and lymphoid cells]L Degos
Tissue Antigens|March 1, 1989
Nomenclature for factors of the HLA system. Comments to the nomenclature committeeL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Do we treat a disease or a patient? A subtle difference with dramatic consequencesL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guidelineL Degos
Pageof 34